Back
argenx SE 10K Form
Sell
37
ARGX
argenx SE
Last Price:
358.73
Seasonality Move:
22.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive ARGX News And Ratings
See the #1 stock for the next 7 days that we like better than ARGX
ARGX Financial Statistics
Sales & Book Value
| Annual Sales: | $1.23B |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $69.22 |
| Price / Book: | 5.19 |
Profitability
| EPS (TTM): | -5.15000 |
|---|---|
| Net Income (TTM): | $-295.05M |
| Gross Margin: | $1.11B |
| Return on Equity: | -9.66% |
| Return on Assets: | -8.14% |
argenx SE Earnings Forecast
Key argenx SE Financial Ratios
- The Gross Profit Margin over the past 4 years for ARGX is 90.39%.
- The Selling, General & Administrative Expenses for ARGX have been equal to 57.86% of Gross Profit Margin.
- The Research & Development expenses have been 70.09% of Revenue.
- The Interest Expense is -0.31% of Operating Income.
- The Net Earning history of ARGX is -24.06% of Total Revenues.
- Per Share Earnings over the last 13 years have been positive in 4 years.
argenx SE Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | ARGX |
| CUSIP: | 04016X |
| Website: | argenx.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 9.75 |
| Quick Ratio: | 8.7 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 92.83 |